As the most widely studied member of IAPs, survivin was significantly overexpressed in most cancers available in Oncomine including colorectal cancer, which was validated by the analysis of survivin expression profile in multiple cancers by GEPIA (Fig. 1a and Figure S1A). This evidence concerns the gene BIRC5 and colorectal cancer.